Jason Pitofsky is VP Controller of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 4,962 shares of REGN, which is worth approximately $3.6 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 149 shares (Common Stock) at a price of $787.0 per share, resulting in proceeds of $117,263. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.96K
18.03% 3M change
n/a 12M change
Total Value Held $3.6 Million

Jason Pitofsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
SELL
Payment of exercise price or tax liability
$117,263 $787.0 p/Share
149 Reduced 2.92%
4,962 Common Stock
Dec 06 2024
BUY
Grant, award, or other acquisition
-
907 Added 15.07%
5,111 Common Stock
Aug 07 2024
SELL
Open market or private sale
$521,090 $1070.0 p/Share
487 Reduced 10.38%
4,204 Common Stock
Aug 07 2024
BUY
Exercise of conversion of derivative security
$181,388 $372.46 p/Share
487 Added 9.41%
4,691 Common Stock
JP

Jason Pitofsky

VP Controller
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN